نتایج جستجو برای: factor v deficiency

تعداد نتایج: 1240345  

Journal: :Journal of clinical pathology 1960
A J QUICK

Human oxalated plasma stored at 4 degrees C. until the prothrombin time is increased beyond 60 sec. is a reliable medium for assaying labile factor (factor V) because its response to added labile factor corresponds quantitatively to that of plasma from patients with congenital deficiency of this factor. Such an agreement is not obtained with plasma stored at 37 degrees C. The stability of labil...

Journal: :Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2017
Hema Subramanian Rakhee Kar Deepak Charles Hitha Babu Pagadalu Ambika Tarun Kumar Dutta

INTRODUCTION Inherited factor V deficiency / Owren's disease has varied clinical manifestations ranging from asymptomatic laboratory abnormalities to massive hemorrhage. The acquired form due to inhibitors following antibiotic therapy, infection, or surgery is less common, and spontaneous development of inhibitors is not known. CASE REPORT An 18-year-old boy presented with bleeding axillary a...

Journal: :the journal of tehran university heart center 0
shokoufeh hajsadeghi rasoul-e-akram hospital, iran university of medical sciences, tehran, iran. roozbeh naghshin rasoul-e-akram hospital, iran university of medical sciences, tehran, iran. maral hejrati students' scientific research center, tehran university of medical sciences, tehran, iran. scottreza jafarian-kerman tehran university of medical sciences, tehran, iran.

factor v leiden deficiency is the most common hereditary hypercoagulable disease in the united states and involves 5% of the caucasian population. up to 30% of patients who present with deep vein thrombosis (dvt) or pulmonary thromboembolism present with this condition. this is a case report of a 36-year-old man who experienced one episode of dvt within the previous year and was admitted to our...

Journal: :Haematologica 2013
Mariasanta Napolitano Muriel Giansily-Blaizot Alberto Dolce Jean F Schved Guenter Auerswald Jørgen Ingerslev Jens Bjerre Carmen Altisent Pimlak Charoenkwan Lisa Michaels Ampaiwan Chuansumrit Giovanni Di Minno Umran Caliskan Guglielmo Mariani

Because of the very short half-life of factor VII, prophylaxis in factor VII deficiency is considered a difficult endeavor. The clinical efficacy and safety of prophylactic regimens, and indications for their use, were evaluated in factor VII-deficient patients in the Seven Treatment Evaluation Registry. Prophylaxis data (38 courses) were analyzed from 34 patients with severe factor VII deficie...

Journal: :Blood 1976
A Rimon S Schiffman D I Feinstein S I Rapaport

A relatively potent antiserum against highly purified, unactivated human factor XI antigen was raised in a rabbit. This antiserum, after concentration, neutralized 50% of the factor XI clotting activity of a standard normal plasma at an antiserum dilution of 1/900. The antiserum was used in a neutralization-inhibition assay to study the relation between factor XI clotting activity and factor XI...

Journal: :Journal of medical genetics 1995
P J Hallam D S Millar M Krawczak V V Kakkar D N Cooper

The factor V Leiden variant, responsible for the phenomenon of activated protein C resistance, was found to be less frequent among British (0.06) and Swedish/Danish (0.15) protein C deficiency patients than previously reported in a Dutch study (0.19). In the Swedish population, a significantly increased frequency of the factor V Leiden allele was apparent in protein C deficiency patients as com...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید